These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28295713)

  • 41. Stevens-Johnson syndrome/toxic epidermal necrolysis induced by pirfenidone.
    de Perosanz-Lobo D; Fernández-Nieto D; Burgos-Blasco P; Aroca-Ruiz M; Fernández-Guarino M
    Indian J Dermatol Venereol Leprol; 2021 [SEASON]; 87(4):542-544. PubMed ID: 34114417
    [No Abstract]   [Full Text] [Related]  

  • 42. [Stevens-Johnson syndrome and toxic epidermal necrolysis in Togo: the role of self-medication].
    Saka B; Kombaté K; Egbohou P; Mouhari-Toure A; Akakpo S; Boukari T; Tchangaï-Walla K; Pitché P
    Ann Dermatol Venereol; 2012 Jun; 139(6-7):486-7. PubMed ID: 22721483
    [No Abstract]   [Full Text] [Related]  

  • 43. Dermatologic emergencies.
    Usatine RP; Sandy N
    Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
    Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
    Michels AW; Ostrov DA
    J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
    Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
    J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Fritsch P
    Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404
    [No Abstract]   [Full Text] [Related]  

  • 49. Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Should Be Kept in Mind in Children with Febrile Neutropenia, Oral Cavity Lesions, and Skin Rash.
    Ataseven E; Yılmaz Bengoa Ş; Ören H
    Turk J Haematol; 2016 Jun; 33(2):170-1. PubMed ID: 26376920
    [No Abstract]   [Full Text] [Related]  

  • 50. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)].
    Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J
    Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toxic epidermal necrolysis in the absence of circulating T cells: a possible role for resident memory T cells.
    Iriki H; Adachi T; Mori M; Tanese K; Funakoshi T; Karigane D; Shimizu T; Okamoto S; Nagao K
    J Am Acad Dermatol; 2014 Nov; 71(5):e214-6. PubMed ID: 25437999
    [No Abstract]   [Full Text] [Related]  

  • 52. Capecitabine: toxic epidermal necrolysis and Stevens-Johnson syndrome.
    Prescrire Int; 2014 Jun; 23(150):157. PubMed ID: 25121151
    [No Abstract]   [Full Text] [Related]  

  • 53. Current agreement on the management of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chen CB; Chung WH
    Br J Dermatol; 2021 Sep; 185(3):484-486. PubMed ID: 34224137
    [No Abstract]   [Full Text] [Related]  

  • 54. Toxic epidermal necrolysis versus cutaneous Graft-Versus-Host Disease in a hematopoietic stem cell transplant recipient: the role of elafin.
    Chen A; Chao K; Rodriguez L; Munday W; Worswick S
    Leuk Lymphoma; 2018 Sep; 59(9):2261-2263. PubMed ID: 29322835
    [No Abstract]   [Full Text] [Related]  

  • 55. Itraconazole-induced Stevens-Johnson syndrome and toxic epidermal necrolysis overlap: Report of a rare incident.
    Das A; Sil A; Mohanty S
    Dermatol Ther; 2020 Nov; 33(6):e14311. PubMed ID: 32959476
    [No Abstract]   [Full Text] [Related]  

  • 56. [Stevens-Johnson syndrome and toxic epidermal necrolysis in children].
    Sotelo-Cruz N
    Gac Med Mex; 2012; 148(3):265-75. PubMed ID: 22820360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Erythema multiforme exudativum, the Stevens-Johnson and Lyell syndromes and their interrelation].
    Korolev IuF
    Vestn Dermatol Venerol; 1981 Aug; (8):44-6. PubMed ID: 7281984
    [No Abstract]   [Full Text] [Related]  

  • 58. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
    Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
    Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Stevens-Johnson syndrome and toxic epidermal necrolysis].
    Kaur-Knudsen D; Zachariae C; Thomsen SF
    Ugeskr Laeger; 2013 Dec; 175(50):3096-9. PubMed ID: 24629532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.